Nasopharyngeal Carcinoma - 31 Studies Found

Completed : Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli
: Nasopharyngeal Carcinoma
: 2014-07-23
Not yet recruiting : Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
: Nasopharyngeal Carcinoma
: 2016-02-29
: Drug: Donafenib donafenib 200mg，bid Other Nam
Not yet recruiting : Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
: Nasopharyngeal Carcinoma
: 2011-08-15
:
  • Drug: Drug: Gemcitabine and cisplatin

Active, not recruiting : Nasopharyngeal Carcinoma Post IMRT
: Nasopharyngeal Carcinoma
: 2015-08-18
Completed : HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma
: Nasopharyngeal Carcinoma
: 2015-08-12
: Procedure: interventional therapy nasopharyngeal carcinoma patients received HepaSphere interventional t
Completed : Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
: Nasopharyngeal Carcinoma
: 2008-06-12
:
  • Drug: Gemcitabine Intravenous

Recruiting : TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma
: Nasopharyngeal Carcinoma
: 2016-09-21
:
  • Other: Drug: Taxol,cisplatin and capecitabine

Recruiting : The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT
: Nasopharyngeal Carcinoma
: 2015-05-28
:
  • Drug: Gemcitabine Experimental
Terminated : SOX as Salvage Treatment in Nasopharyngeal Carcinoma
: Nasopharyngeal Carcinoma
: 2011-07-26
: Drug: S-1 plus oxaliplatin S-1 60 mg BID at day 1-14 Oxaliplatin 100 mg/m2 at day 1 Frequence of cycles:
Completed : Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma
: Nasopharyngeal Carcinoma
: 2011-10-04
:
  • Biological: DNAzyme targeting EBV-LMP1 (DZ1)

Next >>>